These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6603593)

  • 1. Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone.
    Green AR; O'Shaughnessy K; Hammond M; Schächter M; Grahame-Smith DG
    Neuropharmacology; 1983 May; 22(5):573-8. PubMed ID: 6603593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR; DeSouza RJ; Davies EM; Cross AJ
    Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
    Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E
    Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist.
    Colpaert FC; Janssen PA
    Neuropharmacology; 1983 Aug; 22(8):993-1000. PubMed ID: 6604885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):201-9. PubMed ID: 708990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat.
    Yap CY; Taylor DA
    Neuropharmacology; 1983 Jul; 22(7):801-4. PubMed ID: 6604883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin antagonist pirenperone inhibits sexual behavior in the male rat: attenuation by quipazine.
    Mendelson SD; Gorzalka BB
    Pharmacol Biochem Behav; 1985 Apr; 22(4):565-71. PubMed ID: 3158005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A facilitatory role for serotonin in the sexual behavior of the female rat.
    Mendelson SD; Gorzalka BB
    Pharmacol Biochem Behav; 1985 Jun; 22(6):1025-33. PubMed ID: 3161094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to high pressure may produce the 5-HT behavioral syndrome in rats.
    Wardley-Smith B; Hudson S; Doré CJ; Charlett A; Fletcher A; Brammer NT; Minchin MC; Wann KT
    Undersea Biomed Res; 1990 Jul; 17(4):275-86. PubMed ID: 1697708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 5-HT receptor subtype-selective drugs on locomotor activity and motor habituation in the DHT adult rat model.
    Pranzatelli MR; Jappay E; Snodgrass SR
    Pharmacol Biochem Behav; 1987 Jul; 27(3):497-504. PubMed ID: 3116560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The behavioural effects of RU 24969, a suggested 5-HT1 receptor agonist in rodents and the effect on the behaviour of treatment with antidepressants.
    Green AR; Guy AP; Gardner CR
    Neuropharmacology; 1984 Jun; 23(6):655-61. PubMed ID: 6462374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological studies on serotonin-mediated behaviour.
    Green AR
    J Physiol (Paris); 1981; 77(2-3):437-47. PubMed ID: 6457143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Adrenoceptor agonists enhance 5-hydroxytryptamine-mediated behavioural responses.
    Cowen PJ; Grahame-Smith DG; Green AR; Heal DJ
    Br J Pharmacol; 1982 Jun; 76(2):265-70. PubMed ID: 6124294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat.
    Colpaert FC; Meert TF; Niemegeers CJ; Janssen PA
    Psychopharmacology (Berl); 1985; 86(1-2):45-54. PubMed ID: 2862659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.
    Yamamoto T; Walker EA; Woods JH
    J Pharmacol Exp Ther; 1991 Sep; 258(3):999-1007. PubMed ID: 1890629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanisms by which clenbuterol, a beta-adrenoceptor agonist, enhances 5-HT-mediated behaviour and increases metabolism of 5-HT in the brain of the rat.
    Nimgaonkar VL; Green AR; Cowen PJ; Heal DJ; Grahame-Smith DG; Deakin JF
    Neuropharmacology; 1983 Jun; 22(6):739-49. PubMed ID: 6225031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine.
    Costain DW; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):193-200. PubMed ID: 30503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.